De La Cruz Ridao patent opposition analysis

The comprehensive analysis of De La Cruz Ridao opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by De La Cruz Ridao

Patent NumberTitleApplicantOpposition DateOpposition Company
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 29, 2021FARMAPROJECTS SAU

Top companies who are the clients of De La Cruz Ridao

CompanyTotal
FARMAPROJECTS SAU2